Reviva Pharmaceuticals
RVPH
RVPH
39 hedge funds and large institutions have $3.51M invested in Reviva Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
36% less capital invested
Capital invested by funds: $5.44M → $3.51M (-$1.93M)
Holders
39
Holding in Top 10
–
Calls
$576K
Puts
$23K
Top Buyers
| 1 | +$157K | |
| 2 | +$84.1K | |
| 3 | +$82.3K | |
| 4 |
Renaissance Technologies
New York
|
+$79.8K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$44K |
Top Sellers
| 1 | -$1.03M | |
| 2 | -$697K | |
| 3 | -$381K | |
| 4 |
DP
Diadema Partners
Morristown,
New Jersey
|
-$84.2K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$64.8K |